A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer

D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour.

Genes, brain, and behavior·2006

Insulin increases plasma membrane content and reduces phosphorylation of Na(+)-K(+) pump alpha(1)-subunit in HEK-293 cells.

American journal of physiology. Cell physiology·2001

The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio.

Genome research·2001

Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits.

Biochemistry·2000

The Na,K-ATPase alpha4 gene (Atp1a4) encodes a ouabain-resistant alpha subunit and is tightly linked to the alpha2 gene (Atp1a2) on mouse chromosome 1.

Biochemistry·1999

Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study.

Breast cancer research and treatment·1999

Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosis.

Investigational new drugs·2026

First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.

Investigational new drugs·2026

Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verification.

Investigational new drugs·2026

Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.

Investigational new drugs·2026

Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.

Investigational new drugs·2026

Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.

Investigational new drugs·2026

Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.

medRxiv : the preprint server for health sciences·2026

Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation.

bioRxiv : the preprint server for biology·2026

A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.

bioRxiv : the preprint server for biology·2026

Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.

bioRxiv : the preprint server for biology·2026

Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations.

Frontiers in oncology·2026

Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.

medRxiv : the preprint server for health sciences·2026

Related Experiment Videos

A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer

Related Concept Videos

D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour.

Insulin increases plasma membrane content and reduces phosphorylation of Na(+)-K(+) pump alpha(1)-subunit in HEK-293 cells.

The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio.

Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits.

The Na,K-ATPase alpha4 gene (Atp1a4) encodes a ouabain-resistant alpha subunit and is tightly linked to the alpha2 gene (Atp1a2) on mouse chromosome 1.

Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study.

Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosis.

First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.

Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verification.

Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.

Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.

Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.

Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.

Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation.

A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.

Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.

Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations.

Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.

Related Experiment Videos

A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer

Related Concept Videos

Related Articles